-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 1, Sichuan State submitted an application for the first generic listing of linaclotide capsules for the first pharmaceutical company
Figure 1: The situation of products declared by Sichuan Guowei for the production of pharmaceuticals
Source: CED official website
In recent years, irritable bowel syndrome (IBS) is considered to be a global functional disease with the highest incidence.
According to data from Meinnet.
Table 1: TOP10 products for the treatment of constipation in the 2021E retail market
Source: Mi Nei.
At the physical pharmacy terminal in Chinese cities, the total market share of TOP10 products for constipation treatment is expected to reach 98% in 2021, and the market concentration is extremely high
Sichuan Guowei Pharmaceutical is the first company to declare a generic listing of Linaclotide Capsules, and the bioequivalence test of Jiangsu Haosen Pharmaceutical Group is in progress
Source: CDE official website, Minet database
The review data statistics are as of November 2.